Anacor Pharma (ANAC) Files to Offer Common Stock
Tweet
Share
E-mail
Anacor Pharmaceuticals (NASDAQ: ANAC) filed a registration with the U.S. SEC to sell, from time to time, shares of its common stock.
The offering is being made through Cowen and Company, Canaccord Genuity, and Wedbush PacGrow Life Sciences.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- RenovoRx regains Nasdaq minimum bid price compliance
- Gossamer Bio raises up to $250M in private placement for PAH drug
Create E-mail Alert Related Categories
Equity Offerings, SEC FilingsRelated Entities
Cowen & Co, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
